ReviewDisease markers2022

Advance of Serum Biomarkers and Combined Diagnostic Panels in Nonalcoholic Fatty Liver Disease.

Yuping Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.